GW Capital »

Taro Pharmaceutical Industries shares owned by GW Capital

Quarter-by-quarter ownership of Taro Pharmaceutical Industries (TARO) shares owned by GW Capital from 13F filings

Historical chart of GW Capital investment in Taro Pharmaceutical Industries

Tip: Access up to 7 years of quarterly data

All positions including Taro Pharmaceutical Industries held by GW Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taro Pharmaceutical Industries by GW Capital

Quarter filed Position value Share count Share price at filing
2015-12-31 $12M 80k 154.55
2015-09-30 $12M 80k 142.89
2015-06-30 $13M 88k 143.69
2015-03-31 $17M 123k 141.03
2014-12-31 $13M 90k 148.19

More positions owned by GW Capital

Casey's General Stores (CASY)
Darling International (DAR)
Crown Holdings (CCK)
Omega Healthcare Investors (OHI)
Verisk Analytics (VRSK)
Owens-Illinois
Key (KEY)
Xylem (XYL)
Cable One (CABO)
UniFirst Corporation (UNF)
Brookdale Senior Living (BKD)
Prestige Brands Holdings (PBH)
Assured Guaranty (AGO)
Sensient Technologies Corporation (SXT)
Core-Mark Holding Company

View all positions for GW Capital

Top funds holding Taro Pharmaceutical Industries

Krensavage Asset Management
Dimensional Fund Advisors
Brandes Investment Partners
Vanguard Group
ARK Investment Management
Norges Bank Investment Management
Arrowstreet Capital, Limited Partnership
UBS Group
Bank of New York Mellon
Charles Schwab Investment Management
Swiss National Bank
Citadel Advisors
Barclays
Connor, Clark & Lunn Investment Management
Inspire Advisors

View all funds holding Taro Pharmaceutical Industries